OpenVSafe by OpenVAERS
Search V-safe

VY3-26541-37613

3 vaccinations 2 coded responses 19 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
190 / PA
Registered
2021-04-09
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-09
    Registered in v-safe
  2. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-09
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-30
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-05-03
    Dose 2 — Pfizer-BioNTech
  14. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-05-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-05-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-25
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-11
    Survey response — day 35, dose 2
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: Cold symptoms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-08-02
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2022-01-09
    Dose 3 — Pfizer-BioNTech
  23. 2022-07-10
    Survey response — 6 months, dose 3
    MedDRA: Fatigue, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sore throat, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-07-10
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  25. 2022-07-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-05-03Pfizer-BioNTech
32022-01-09Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-07-10 Unsuccessful

Free text

Release 9 — day 35, dose 2

2021-06-11

Symptoms: Cold symptoms

Release 12 — 6 months, dose 3

2022-07-10

Symptoms: Sore throat, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDNasopharyngitis ✓ ✓ ✓
SDOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…